Ariel Precision Medicine

We wish you a joyous holiday season and a wonderful New Year!

IT'S WORLD PANCREATIC CANCER DAY! 💜📣🎗 Let's turn the world purple today to show support for those facing this disease! Here's how you can join in: 📱Put on your best purple and post on social media! Don't forget to tag @PanCAN and #PanCANawareness 💌 SHARE this post with your social media community to help spread the word 💻 Join us TODAY at 11 a.m. PT/2 p.m. ET for our webinar "Early Detection can Change the Course for Pancreatic Cancer" It takes all of us to raise awareness for pancreatic cancer! 💜 Want to do more? Donate today at pancan.org/awareness to help PanCAN fund leading-edge research and make sure every person faced with pancreatic cancer has somewhere to turn.

💜 On World Pancreatic Cancer Day, Hope Begins with Innovation 💜 Pancreatic cancer is one of the most challenging diseases to detect and treat early, but we are working diligently to improve screening and detection methods for this deadly cancer. We are transforming the fight against pancreatic cancer with a groundbreaking approach to early detection. By going beyond genetics, Pancreatic Cancer Biomarker and Risk SNaP-Shot™ provides personalized insights that clarify cancer risk and guide proactive care for patients. ✨ Pancreatic Cancer Biomarker and Risk SNaP-Shot™ identifies high-risk patients who can benefit from pancreatic cancer surveillance—empowering patients and healthcare providers with the knowledge needed to act early, when it matters most. This isn’t just about medicine; it’s about changing lives. Every early diagnosis brings hope, every personalized plan provides a path forward, and every innovation gets us closer to a world where pancreatic cancer is caught and treated in time 💜. 🔍 Early Detection Saves Lives 💡 Innovation Changes Futures Together, we can make early detection the norm and give patients the fighting chance they deserve. #WorldPancreaticCancerDay #EarlyDetectionSavesLives #PrecisionMedicine #PancreaticCancerAwareness 💜

Join Pancreatic Cancer Action Network on #WorldPancreaticCancerDay for a conversation with an incredible group of PanCAN community members who are changing the course for #pancreaticcancer.  RSVP for their free virtual event at pancan.org/wpcd2024 | #PanCANawareness #Gastroenterology #Healthcare #Patientcare

November is Pancreatic Cancer Awareness Month, and Ariel Precision Medicine is proud to join Pancreatic Cancer Action Network to Change the Course of pancreatic cancer. 💜 Early detection is critical to increasing survival, but today there is no standard test to find pancreatic cancer early. Help us raise awareness about this disease and the steps everyone can take to be proactive about their health. Visit pancan.org/awareness to learn more. | #PanCANawareness

The greatest opportunity to improve #PancreaticCancer survival is through screening and monitoring high-risk individuals (HRI) to make an early diagnosis. Ariel created Pancreatic Cancer Biomarker and Risk SNaP-Shot™ to support and guide pancreatic cancer screening by helping you determine which patients may be HRI. Pancreatic Cancer Biomarker and Risk SNaP-Shot™ is a patient risk stratification tool to identify the subset of patients who are HRI and most likely to benefit from an image-based PDAC screening program by: 1. Combining genetic risk factors with known non-genetic risk factors to calculate age, sex and ancestry-adjusted risk. 2. Combining absolute risk and new-onset symptoms (e.g. new onset diabetes, NOD) to calculate the likelihood of PDAC developing in the individual within the next 12 months. 3. Assessing CA 19-9 and CEA genetics (FUT2/FUT3) to help interpret laboratory results. Learn more and get started helping your patients today: https://lnkd.in/gdVyfu29 #healthcare #pancreaticcancer #biotechnology #patientcare #healthcaretechnology

Nonspecific signals of occult Pancreatic Ductal Adenocarcinoma (#PDAC) (such as new onset diabetes; NOD) often occur up to 3 years before PDAC is diagnosed – typically at Stage 4 where long-term survival is poor.* Ariel Precision Medicine's Pancreatic Cancer Biomarker and Risk SNaP-Shot™ is a patient risk stratification tool that integrates multiple genetic risk factors with certain clinical risk factors and biomarkers (adjusted for underlying genetics) to help you answer this critical question. Learn more about our Pancreatic Cancer Biomarker and Risk SNaP-Shot™: https://lnkd.in/gdVyfu29 * Note: Nonspecific biomarkers of occult PDAC include new onset (within the last 1-3 years) of diabetes, acute pancreatitis, chronic pancreatitis, exocrine pancreatic secretion / maldigestion, increased LFTs (especially biliary, including jaundice, clay-colored stools), unexplained weight loss, unexplained abdominal pain, loss of appetite and/or others. #gastroenterology #oncology #healthcare #healthcareproviders #medicalproviders #biotechnology #genetics #PancreaticCancerAwarenessMonth #pancreaticcancer

I want to extend my gratitude to the faculty in the department of biomedical engineering at #CarnegieMellonUniversity for inviting me as today’s seminar speaker to discuss the the future of medicine and majoradvances at #Ariel Precision Medicine. Thank you for the warm welcome and engaging discussion With faculty and Trainees throughout the day. #BiomedicalEngineering #SeminarSpeaker #PrecisionMedicine .

Join our Co-Founder and CSO, David C Whitcomb MD PhD, tomorrow, Sept. 12th, at Carnegie Mellon University from 9:30-10:30 AM (EST) for a fantastic and informative presentation on #PrecisionMedicine. In his presentation, he aims to: 1. Highlight specific issues within the current paradigm of #WesternMedicine. 2. Emphasize the importance of considering multiple #GeneticVariants in each subject. 3. Provide examples of how precision medicine can deliver clear clinical decision support information to #HealthcareProviders and patients, anywhere in the world, within seconds. Location: Porter Hall (PH) 100, CMU Campus Thursday, September 12, 2024 (9:30-10:30AM)

Rebecca's Wish is a proud partner with Ariel Precision Medicine, a leading authority in the field of genetic testing, to provide a vital resource for families nationwide. This is a groundbreaking collaboration that revolutionizes the way families are supported and affected by rare and misunderstood diseases. Families facing the challenges of a child with rare, painful, and often misdiagnosed diseases, can now request and receive at-home genetic tests at no cost. Through this initiative, Rebecca’s Wish aims to empower families by giving them crucial insight into the genetic drivers of their child's condition, which subsequently paves the way for more informed treatment decisions and personalized care plans. We are committed to covering 100% of the costs associated with these genetic tests, thanks to the unwavering support of our generous sponsors and donors. It is our firm belief that no family should face financial barriers when seeking answers and solutions for the health of a child. This collaboration represents a significant milestone in our mission to provide comprehensive support and resources to families navigating the complexities of rare diseases. Together with Ariel Precision Medicine, we are dedicated to fostering a community of understanding, compassion, and empowerment. #RebeccasWish #PediatricPancreatitis #GeneticTesting #RareDiseases https://lnkd.in/g-PjR48h